A Clinical Trial to Evaluate the Effects of A Supplement on Symptoms of Menopause and Overall Well-being
Condition(s) studied
Investigational drug(s) / intervention(s)
Primal Meno+ Supplement: All 40 participants take one capsule of Primal Meno+ daily with their first meal of the day for 12 weeks.
Study summary
This study evaluates the effects of Primal Harvest's Primal Meno+ supplement on symptoms of menopause and overall well-being in females aged 40-60 who are currently menopausal and experiencing at least two menopausal symptoms. Over a 12-week period, 40 participants will take one capsule of the test product daily with their first meal of the day.
Participants will complete self-reported questionnaires at Baseline, Week 4, Week 8, and Week 12 to assess menopausal symptoms (including hot flashes, night sweats, sleep quality, stress resilience, and emotional well-being) and overall health and well-being. This is a single-arm, open-label, virtual trial with no randomization or blinding.
Eligibility
Primary outcome measure(s)
- Change in Symptoms of Menopause — Baseline, Week 4, Week 8, and Week 12
Assessed via the Menopausal Rating Scale (MRS) validated self-reported questionnaire - Change in Hot Flashes — Baseline, Week 4, Week 8, and Week 12
Assessed via self-reported questionnaire - Change in Night Sweats — Baseline, Week 4, Week 8, and Week 12
Assessed via self-reported questionnaire - Change in Stress Resilience — Baseline, Week 4, Week 8, and Week 12
Assessed via self-reported questionnaire - Change in Sleep Quality — Baseline, Week 4, Week 8, and Week 12
Assessed via self-reported questionnaire - Change in Emotional Well-being — Baseline, Week 4, Week 8, and Week 12
Assessed via self-reported questionnaire
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Citruslabs | Las Vegas | Nevada |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07903480 on ClinicalTrials.gov ↗ ← All trials in the USA